As interest in essential oils (EOs) for their therapeutic, antibacterial, and antifungal properties continues to grow—driving demand for high-quality products in both medicinal and industrial ...

Explore the innovative generative AI method transforming drug discovery and material science at unprecedented speeds.

Enzymes with specific functions are becoming increasingly important in industry, medicine and environmental protection. For example, they make it possible to synthesize chemicals in a more ...

For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...

The FDA issued draft guidance Jan. 21 proposing the use of minimal residual disease and complete response as primary endpoints to support accelerated approval of drugs for multiple myeloma. The draft ...

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...

Many natural compounds that act on the human body provide active ingredients for medicines or clues for developing them, and ...

Chemical biology increasingly benefits from the close integration of experimental structural techniques and computational ...

Schrödinger (SDGR) and Revvity (RVTY) on Friday announced collaborations with Eli Lilly (LLY) to integrate their respective drug development software offerings with the Indiana-based pharma giant’s ...

Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug discovery and development by ...

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug ...